GWSG
SRNE

GPS Wealth Strategies Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

GPS Wealth Strategies Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,581
Closed -$2K – 1171
2022
Q3 		$2K Hold
1,581
– – ﹤0.01% 1059
2022
Q2 		$3K Buy
1,581
+200
+14% +$346 ﹤0.01% 1000
2022
Q1 		$3K Hold
1,381
– – ﹤0.01% 951
2021
Q4 		$6K Sell
1,381
-45
-3% -$279 ﹤0.01% 843
2021
Q3 		$11K Hold
1,426
– – ﹤0.01% 704
2021
Q2 		$14K Hold
1,426
– – ﹤0.01% 679
2021
Q1 		$11K Buy
+1,426
New +$15.1K ﹤0.01% 664

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM